Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications

References

• Norrby SR, Nord CE, Finch R; European Society of Clinical Microbiology and Infectious Diseases. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect. Dis.5, 115–119 (2005).
   PubMed Web of Science ®Google Scholar
• Spellberg B, Guidos R, Gilbert D et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin. Infect. Dis.46, 155–164 (2008).
   PubMed Web of Science ®Google Scholar
• Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell128, 1037–1050 (2007).
   PubMed Web of Science ®Google Scholar
• Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin. Infect. Dis.21, 1378–1385 (1995).
   PubMed Web of Science ®Google Scholar
• Goossens H, Ferech M, Vander Stichele R, Elseviers M and the ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet365, 579–587 (2005).
   PubMed Web of Science ®Google Scholar
• Goettsch W, van Pelt W, Nagelkerke N et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands. J. Antimicrob. Chemother.46, 223–228 (2000).
   PubMed Web of Science ®Google Scholar
• Gasink LB, Fishman NO, Weiner MG, Nachamkin I, Bilker WB, Lautenbach E. Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact. Am. J. Med.119, 526. e19–e25 (2006).
   Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev.18, 657–686 (2005).
   PubMed Web of Science ®Google Scholar
• Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis.8, 159–166 (2008).
   PubMed Web of Science ®Google Scholar
• Lepper PM, Grusa E, Reichl H, Högel J, Trautmann M. Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.46, 2920–2925 (2002).
   PubMed Web of Science ®Google Scholar
• Scheetz MH, Knechtel SA, Malczynski M, Postelnick MJ, Qi C. Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption. Antimicrob. Agents Chemother.52, 2256–2259 (2008).
   PubMed Web of Science ®Google Scholar
• Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N. Engl. J. Med.337, 441–446 (1997).
   PubMed Web of Science ®Google Scholar
• Nowak R. Hungary sees an improvement in penicillin resistance. Science264, 364 (1994).
   PubMedGoogle Scholar
• Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc. Natl Acad. Sci. USA96, 1152–1156 (1999).
   PubMed Web of Science ®Google Scholar
• Guillemot D, Varon E, Bernede C et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin. Infect. Dis.41, 930–938 (2005).
   PubMed Web of Science ®Google Scholar
• Hughes VM, Datta N. Conjugative plasmids in bacteria of the ‘pre-antibiotic’ era. Nature302, 725–726 (1983).
   PubMed Web of Science ®Google Scholar
• Mare IJ. Incidence of R factors among Gram negative bacteria in drug-free human and animal communities. Nature220, 1046–1047 (1968).
   PubMed Web of Science ®Google Scholar
• Walson JL, Marshall B, Pokhrel BM, Kafle KK, Levy SB. Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. J. Infect. Dis.184, 1163–1169 (2001).
   PubMedGoogle Scholar
• Grenet K, Guillemot D, Jarlier V et al. Antibacterial resistance, Wayampis Amerindians, French Guyana. Emerg. Infect. Dis.10, 1150–1153 (2004).
   PubMed Web of Science ®Google Scholar
• Bartoloni A, Bartalesi F, Mantella A et al. High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption. J. Infect. Dis.189, 1291–1294 (2004).
   PubMed Web of Science ®Google Scholar
• Bartoloni A, Pallecchi L, Rodríguez H et al. Antibiotic resistance in a very remote Amazonas community. Int. J. Antimicrob. Agents (2008) (In press).
   PubMedGoogle Scholar
• Bartoloni A, Pallecchi L, Benedetti M et al. Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg. Infect. Dis.12, 907–913 (2006).
   PubMed Web of Science ®Google Scholar
• Pallecchi L, Lucchetti C, Bartoloni A et al. Population structure and resistance genes in antibiotic-resistant bacteria from a remote community with minimal antibiotic exposure. Antimicrob. Agents Chemother.51, 1179–1184 (2007).
   PubMed Web of Science ®Google Scholar
• Huber WG, Korica D, Neal TP, Schnurrenberger PR, Martin RJ. Antibiotic sensitivity patterns and R factors in domestic and wild animals. Arch. Environ. Health22, 561–567 (1971).
   PubMed Web of Science ®Google Scholar
• Pagano A, Nardi G, Bonaccorso C et al. Faecal bacteria of wild ruminants and the Alpine marmot. Vet. Res. Commun.9, 227–232 (1985).
   PubMed Web of Science ®Google Scholar
• Caprioli A, Donelli G, Falbo V, Passi C, Pagano A, Mantovani A. Antimicrobial resistance and production of toxins in Escherichia coli strains from wild ruminants and the Alpine marmot. J. Wild. Dis.27, 324–327 (1991).
   PubMed Web of Science ®Google Scholar
• Rolland RM, Hausfater G, Marshall B, Levy SB. Antibiotic-resistant bacteria in wild primates: increased prevalence in baboons feeding on human refuse. Appl. Environ. Microbiol.49, 791–794 (1985).
   PubMed Web of Science ®Google Scholar
• Routman E, Miller RD, Phillips-Conroy J, Hartl DL. Antibiotic resistance and population structure in Escherichia coli from free-ranging African yellow baboons. Appl. Environ. Microbiol.50, 749–754 (1985).
   PubMedGoogle Scholar
• Gilliver MA, Bennett M, Begon M, Hazel SM, Hart CA. Antibiotic resistance in wild rodents. Nature401, 233–234 (1999).
   PubMed Web of Science ®Google Scholar
• Gilliver MA, Bennett M, Begon M, Hazel SM, Hart CA. Reply to Osterblad et al.Nature409, 38 (2001).
   Google Scholar
• Osterblad M, Norrdahl K, Korpimaki E, Huovinen P. How wild are wild mammals? Nature409, 37–38 (2001).
   PubMed Web of Science ®Google Scholar
• Skurnik D, Ruimy R, Andremont A et al. Effect of human vicinity on antimicrobial resistance and integrons in animal faecal Escherichia coli. J. Antimicrob. Chemother.57, 1215–1219 (2006).
   PubMed Web of Science ®Google Scholar
• Costa D, Poeta P, Saenz Y et al. Detection of Escherichia coli harbouring extended-spectrum β-lactamases of the CTX-M, TEM and SHV classes in faecal samples of wild animals in Portugal. J. Antimicrob. Chemother.58, 1311–1312 (2006).
   PubMed Web of Science ®Google Scholar
• Costa D, Poeta P, Saenz Y et al. Mechanisms of antibiotic resistance in Escherichia coli recovered from wild animals. Microb. Drug Res.14, 71–77 (2008).
   PubMed Web of Science ®Google Scholar
• Souza V, Rocha M, Valera A, Eguiarte LE. Genetic structure of natural populations of Escherichia coli in wild hosts on different continents. Appl. Environ. Microbiol.65, 3373–3385 (1999).
   PubMed Web of Science ®Google Scholar
• Sherley M, Gordon DM, Collignon PJ. Variations in antibiotic resistance profile in Enterobacteriaceae isolated from wild Australian mammals. Environ. Microbiol.2, 620–631 (2000).
   PubMed Web of Science ®Google Scholar
• Livermore DM, Warner M, Hall LMC et al. Antibiotic resistance in bacteria from magpies (Pica pica) and rabbits (Oryctolagus cuniculus) from west Wales. Environ. Microbiol.3, 658–661 (2001).
   PubMed Web of Science ®Google Scholar
• Lillehaug A, Bergsjo B, Schau J, Bruheim T, Vikoren T, Handeland K. Campylobacter spp., Salmonella spp., verocytotoxic Escherichia coli, and antibiotic resistance in indicator organisms in wild cervids. Acta Vet. Scand.46, 23–32 (2005).
   PubMed Web of Science ®Google Scholar
• Middleton JH, Ambrose A. Enumeration and antibiotic resistance patterns of fecal indicator organisms isolated from migratory Canada geese (Branta canadensis). J. Wild. Dis.41, 334–341 (2005).
   PubMed Web of Science ®Google Scholar
• D’Costa VM, McGrann KM, Hughes DW, Wright GD. Sampling the antibiotic resistome. Science311, 374–377 (2006).
   PubMed Web of Science ®Google Scholar
• Wright GD. The antibiotic resistome: the nexus of chemical and genetic diversity. Nature Rev. Microbiol.5, 175–186 (2007).
   PubMed Web of Science ®Google Scholar
• Sjolund M, Bonnedahl J, Hernandez J et al. Dissemination of multidrug-resistant bacteria into the Arctic. Emerg. Infect. Dis.14, 70–72 (2008).
   PubMed Web of Science ®Google Scholar
• Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr. Opin. Microbiol.2, 489–493 (1999).
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Perrot V, Levin BR. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc. Biol. Sci.264, 1287–1291 (1997).
   PubMed Web of Science ®Google Scholar
• Salyers AA, Amabile-Cuevas CF. Why are antibiotic resistance genes so resistant to elimination? Antimicrob. Agents Chemother.41, 2321–2325 (1997).
   PubMed Web of Science ®Google Scholar
• Lenski RE. Bacterial evolution and the cost of antibiotic resistance. Int. Microbiol.1, 265–270 (1998).
   PubMedGoogle Scholar
• Levin BR, Perrot V, Walker N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics154, 985–997 (2000).
   PubMed Web of Science ®Google Scholar
• Enne VI, Delsol AA, Davis GR, Hayward SL, Roe JM, Bennett PM. Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element. J. Antimicrob. Chemother.56, 544–551 (2005).
   PubMedGoogle Scholar
• Ramadhan AA, Hegedus E. Survivability of vancomycin resistant enterococci and fitness cost of vancomycin resistance acquisition. J. Clin. Pathol.58, 744–746 (2005).
   PubMed Web of Science ®Google Scholar
• Sander P, Springer B, Prammananan T et al. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother.46, 1204–1211 (2002).
   PubMed Web of Science ®Google Scholar
• Enne VI, Bennett PM, Livermore DM, Hall LM. Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure. J. Antimicrob. Chemother.53, 958–963 (2004).
   PubMedGoogle Scholar
• Luo N, Pereira S, Sahin O et al. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc. Natl Acad. Sci. USA102, 541–546 (2005).
   PubMed Web of Science ®Google Scholar
• Alonso A, Sanchez P, Martinez JL. Environmental selection of antibiotic resistance genes. Environ. Microbiol.3, 1–9 (2001).
   PubMed Web of Science ®Google Scholar
• Summers AO. Generally overlooked fundamentals of bacterial genetics and ecology. Clin. Infect. Dis.34(Suppl. 3), S85–S92 (2002).
   PubMed Web of Science ®Google Scholar
• Aminov RI, Mackie RI. Evolution and ecology of antibiotic resistance genes. FEMS Microbiol. Lett.271, 147–161 (2007).
   PubMed Web of Science ®Google Scholar
• Rawlings DE. Proteic toxin–antitoxin, bacterial plasmid addiction systems and their evolution with special reference to the pas system of pTF-FC2. FEMS Microbiol. Lett.176, 269–277 (1999).
   PubMedGoogle Scholar
• Singer RS, Ward MP, Maldonado G. Can landscape ecology untangle the complexity of antibiotic resistance? Nature Rev. Microbiol.4, 943–952 (2006).
   PubMed Web of Science ®Google Scholar